Instructions on How to Receive Credit
- Participants must review the materials on accreditation information, target audience, learning objectives, and disclosure information.
- Complete the entire activity, pre/post-test and evaluation.
- After passing the post-test, print out your electronic CE certificate.
- In order to successfully complete this activity learners must achieve a minimum of 65% on the post-test.
This activity is supported by an educational grant from Genentech.
This activity is sponsored by the Institute for Continuing Healthcare Education.
Release Date: February 11, 2014
Expiration Date: February 11, 2015
Accreditation Statements Physicians
The Institute for Continuing Healthcare Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Institute for Continuing Healthcare Education designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Institute for Continuing Healthcare Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity offers 0.75 contact hours to participating nurses. This credit may be applied toward licensure requirements in those states that recognize American Nurses Credentialing Center's Commission on Accreditation (ANCC-COA) accredited providers.
Accreditation applies solely to educational activities and does not imply approval or endorsement of any commercial product by the ANCC-COA.
Institute for Continuing Healthcare Education is approved by the California Board of Registered Nursing, Provider Number 13313. The Institute for Continuing Healthcare Education approves this activity for 0.75 contact hours.
It is the policy of the Institute for Continuing Healthcare Education (the Institute) that the education presented within Institute-provided, CE-certified activities be unbiased and based upon scientific evidence. To help participants make judgments about the presence of bias, the Institute provides information that planners, teachers, authors, developers, and activity managers have disclosed about financial relationships they have with commercial entities that produce or market products or services related to the content of this educational activity. Any relationships that an individual may have with commercial entities have been disclosed and reviewed, and any potential conflicts have been resolved.
Relationships are abbreviated as follows: E, Educational Planning Committee; G, Grant/research support recipient; A, Advisor/review panel member/educational planning committee; C, Consultant/Independent Contractor; SS, Stock shareholder; SB, Speaker bureau; PE, Promotional Event Talks; H, Honoraria; O, Other.
Educational Planning Committee
Daniel Berg, MD
University of Washington
Dr. Berg has disclosed that he does not have any relevant financial relationships specific to the subject matter of the content of the activity.
Karl Lewis, MD
University of Colorado School of Medicine
Dr. Lewis has disclosed the following relevant financial relationships that have occured in the last 12 months: Genentech/A; Genentech, Novartis/G.
Lois Loescher, PhD, RN
College of Nursing
University of Arizona
Dr. Loescher has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content of the activity.
Laura Ninger, ELS, Medical Writer
Ninger Medical Communications, LLC
Ms. Ninger has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content of the activity.
Content Peer Reviewer
Natasha Mesinkovska, MD, PhD
Dr. Mesinkovska has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content of the activity.
Activity Development and Management Team
Cathy Pagano, CCMEP; Scott Kober, MBA, CCMEP; Sandra Davidson; and Megan Small are employees of the Institute and have no relationships to disclose.
Off-label Product Disclosure
This educational activity includes discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.